Skip to content
Yog Pharma
Metabolic and endocrineSynthetic thyroid hormone (T4)

Levothyroxine Sodium is a synthetic thyroid hormone (T4) indicated for hypothyroidism and pituitary TSH suppression. We supply it to US manufacturers of tablets, capsules and injection.

CAS55-03-8798.9 g/molC15H10I4NNaO4
2D structure of Levothyroxine Sodium, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 23666112) and FDA’s substance registry

CAS number

55-03-8

Molecular formula

C15H10I4NNaO4

Molecular weight

798.9g/mol

FDA UNII

IUPAC name

sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate

InChIKey

YDTFRJLNMPSCFM-YDALLXLXSA-M

Appearance
Almost white to pale brownish-yellow powder, or fine, slightly colored crystalline powder.
Solubility
Very slightly soluble in water and slightly soluble in ethanol. Dissolves in dilute solutions of alkali hydroxides.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

A narrow therapeutic index drug dosed in micrograms. The API degrades with heat, light and moisture, so potency, water content and stability data carry more weight here than price.

On the US market

Reference product
SynthroidNDA 021402
Approved ANDAs
11 with a marketed product
Approved forms and strengths
  • Tablet 0.025 mg to 0.3 mg, in 12 strengths
  • Oral solution 13 mcg/mL to 175 mcg/mL, in 12 strengths
  • Capsule 0.013 mg to 0.2 mg, in 12 strengths
  • Powder for injection 100 mcg per vial, 200 mcg per vial, 500 mcg per vial

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com